Panacea Innovation Ltd - 16 May 2025 Form 3 Insider Report for Atara Biotherapeutics, Inc. (ATRA)
- Role
- 10%+ Owner
- Signature
- Panacea Innovation Limited By: /s/ James Huang, Founding Managing Partner
- Issuer symbol
- ATRA
- Transactions as of
- 16 May 2025
- Net transactions value
- $0
- Form type
- 3
- Filing time
- 21 May 2025, 18:00:04 UTC
- Next filing
- 21 Jul 2025
- SEC
- View on sec.gov
Reporting Owners (2)
| Name | Relationship | Address | Signature | Signature date | CIK |
|---|---|---|---|---|---|
| Panacea Innovation Ltd | 10%+ Owner | C/O MAPLES CORPORATE SERVICES LIMITED,, UGLAND HOUSE, GRAND CAYMAN, CAYMAN ISLANDS | Panacea Innovation Limited By: /s/ James Huang, Founding Managing Partner | 21 May 2025 | 0002010692 |
| Huang James | Director, 10%+ Owner | C/O MAPLES CORPORATE SERVICES LIMITED,, UGLAND HOUSE, GRAND CAYMAN, CAYMAN ISLANDS | /s/ James Huang | 21 May 2025 | 0001573160 |
Transactions Table
| Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Ownership | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|
| holding | ATRA | Common Stock | 1,330,665 | 16 May 2025 | See Foonotes | F1, F2 |
Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)
| Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Underlying Class | Amount | Exercise Price | Ownership | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| holding | ATRA | Warrants | 16 May 2025 | Common Stock | 307,900 | $0.000100 | See Foonotes | F2, F3, F4 |
* An asterisk sign (*) next to the price indicates that the price is likely invalid.
Explanation of Responses:
| Id | Content |
|---|---|
| F1 | Represents securities held by Panacea Venture Healthcare Fund II, L.P. |
| F2 | James Huang is the sole owner of Panacea Innovation Limited, which is the sole owner of Panacea Venture Healthcare Fund II GP Company, Ltd. ("Fund II GP") and Panacea Opportunity Fund I GP Company, Ltd. ("Opportunity Fund GP"), which are the general partners of Panacea Venture Healthcare Fund II, L.P. and Panacea Opportunity Fund I, L.P. As a result, each of the Reporting Persons may be deemed to share beneficial ownership of the securities held of record by Panacea Venture Healthcare Fund II, L.P. and Panacea Opportunity Fund I, L.P., but each disclaims such beneficial ownership. |
| F3 | The warrants are immediately exercisable and do not expire. Pursuant to the terms of the warrants, no portion of the warrants held by a holder may be exercised to the extent that, after giving effect to the attempted exercise, such holder, together with such holder's affiliates and any other person whose beneficial ownership of the Issuer's common stock would be aggregated with such holder's for the purposes of Section 13(d) of the Exchange Act, would beneficially own in excess of 19.99% of the outstanding common stock. |
| F4 | Represents securities held by Panacea Opportunity Fund I, L.P. |